Table 1 Distribution by age, age at diagnosis and FEV1% of the 2012 study population between the two groups of the study cohort before pairing
From: Quality of care in cystic fibrosis: assessment protocol of the French QIP PHARE-M
Comparison of the two groups | PHARE-M (N = 1051) | Control (N = 1962) | ||||
|---|---|---|---|---|---|---|
Comparison of Ages | Avg. | Med. | Max. | Avg. | Med. | Max. |
Age of patients (years) | 15.0 | 13.0 | 62 | 18.0 | 17.0 | 74 |
Age at diagnosis (years) | 2.0 | 0.1 | 51 | 3.2 | 0.2 | 71 |
Comparison of FEV1% | Avg. | LLM | ULM | Avg. | LLM | ULM |
FEV1% | 83 | 81,55 | 84,45 | 75,48 | 74,33 | 76,64 |